Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.06
+0.31 (4.59%)
At close: Aug 19, 2026, 4:00 PM EDT
7.18
+0.12 (1.70%)
After-hours: Aug 19, 2026, 6:54 PM EDT

Foghorn Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-64.58-74.28-86.62-98.43-108.88-101.32
Depreciation & Amortization
2.123.333.123.453.323.23
Loss (Gain) From Sale of Assets
0.030.03-00.01-
Asset Writedown & Restructuring Costs
5.915.912.4---
Loss (Gain) From Sale of Investments
-1.67-1.93-4.61-2.65-1.30.18
Stock-Based Compensation
9.9110.411.8916.1914.348.38
Other Operating Activities
0.712.575.685.214.585.84
Change in Accounts Receivable
----300-300
Change in Accounts Payable
-0.120.48-2.480.851.610.14
Change in Unearned Revenue
-36.74-30.91-22.6-34.16-14.23336.48
Change in Other Net Operating Assets
0.18-1.71-7.19-8.57-5.84-3.17
Operating Cash Flow
-84.24-86.1-100.41-118.11193.61-50.25
Operating Cash Flow Growth
------
Capital Expenditures
-0.05-0.05-0.91-1.22-1.21-3.31
Investment in Securities
28.17112.09-29145.67-243.1139.49
Investing Cash Flow
28.12112.04-29.9144.45-244.3236.17
Long-Term Debt Repaid
------21.21
Net Debt Issued (Repaid)
------21.21
Issuance of Common Stock
50.731.02106.011.781.7643.62
Other Financing Activities
-0.35--0.59---
Financing Cash Flow
50.381.02105.431.781.7622.42
Net Cash Flow
-5.7426.96-24.8828.12-48.958.34
Free Cash Flow
-84.29-86.15-101.31-119.33192.4-53.56
Free Cash Flow Growth
------
Free Cash Flow Margin
-229.43%-278.72%-448.24%-349.38%1000.63%-4060.88%
Free Cash Flow Per Share
-1.27-1.37-1.84-2.844.63-1.44
Levered Free Cash Flow
-51.95-35.23-40.3-48.87250.45-329.38
Unlevered Free Cash Flow
-51.95-35.23-40.3-48.87250.45-328.18
Cash Interest Paid
-----1.72
Cash Income Tax Paid
00.010.863.55--
Change in Working Capital
-36.68-32.14-32.27-41.88281.5533.44
SEC Filings: 10-K · 10-Q